{
    "nct_id": "NCT02543710",
    "official_title": "Biomarker Guided Treatment in Gynaecological Cancer",
    "criteria": {
        "raw_text": "Inclusion Criteria part 1:\n\nAll patients referred to a participating research centre with suspicion of or confirmed endometrial cancer.\n\nExclusion Criteria part 1:\n\n1. Patients who do not have endometrial cancer\n2. Patients who will or cannot give informed consent (including language barriers)\n3. Patients \\<18 years of age\n4. Patients who will not get surgical treatment for their endometrial cancer\n\nInclusion criteria part 2:\n\n1. Patients with endometrial or epithelial ovarian cancer who following routine clinical guidelines are offered weekly taxane (paclitaxel) treatment. This will often be a third or fourth line treatment, i.e. patients with advanced disease.\n2. Technical possibility to obtain a new tissue biopsy to determine stathmin level in the tumour recurrence.\n\nExclusion criteria part 2:\n\n1. Patients not suffering from endometrial or epithelial ovarian cancer\n2. Patients \\<18 years of age\n3. Patients who do not agree to the proposed treatment or will receive (part of) the treatment in a non-participating centre\n4. Patients who cannot or do not want to give informed consent (including language barriers)\n\nsex: FEMALE\n\nminimumAge: 18 Years\n\nmaximumAge: 95 Years\n\nstdAges: ['ADULT', 'OLDER_ADULT']",
        "inclusion": "1. All patients referred to a participating research centre with suspicion of or confirmed endometrial cancer.\n2. Patients with endometrial or epithelial ovarian cancer who following routine clinical guidelines are offered weekly taxane (paclitaxel) treatment. This will often be a third or fourth line treatment, i.e. patients with advanced disease.\n3. Technical possibility to obtain a new tissue biopsy to determine stathmin level in the tumour recurrence.",
        "exclusion": "1. Patients who do not have endometrial cancer\n2. Patients who will or cannot give informed consent (including language barriers)\n3. Patients <18 years of age\n4. Patients who will not get surgical treatment for their endometrial cancer\n5. Patients not suffering from endometrial or epithelial ovarian cancer\n6. Patients <18 years of age\n7. Patients who do not agree to the proposed treatment or will receive (part of) the treatment in a non-participating centre\n8. Patients who cannot or do not want to give informed consent (including language barriers)"
    }
}